Methylprednisolone succinate
Modify Date: 2024-01-09 12:17:10
Methylprednisolone succinate structure
|
Common Name | Methylprednisolone succinate | ||
|---|---|---|---|---|
| CAS Number | 2921-57-5 | Molecular Weight | 474.543 | |
| Density | 1.3±0.1 g/cm3 | Boiling Point | 689.6±55.0 °C at 760 mmHg | |
| Molecular Formula | C26H34O8 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 230.7±25.0 °C | |
Use of Methylprednisolone succinateMethylprednisolone succinate is a synthetic glucocorticoid and widely used as an anti-inflammatory agent. |
| Name | 4-[2-[(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethoxy]-4-oxobutanoic acid |
|---|---|
| Synonym | More Synonyms |
| Description | Methylprednisolone succinate is a synthetic glucocorticoid and widely used as an anti-inflammatory agent. |
|---|---|
| Related Catalog | |
| Target |
glucocorticoid receptor[1] |
| References |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 689.6±55.0 °C at 760 mmHg |
| Molecular Formula | C26H34O8 |
| Molecular Weight | 474.543 |
| Flash Point | 230.7±25.0 °C |
| Exact Mass | 474.225372 |
| PSA | 138.20000 |
| LogP | 2.69 |
| Vapour Pressure | 0.0±4.9 mmHg at 25°C |
| Index of Refraction | 1.593 |
| Storage condition | 2-8℃ |
| RIDADR | NONH for all modes of transport |
|---|---|
| HS Code | 2942000000 |
|
~%
Methylprednisol... CAS#:2921-57-5 |
| Literature: Anderson; Conradi; Lambert Journal of Pharmaceutical Sciences, 1984 , vol. 73, # 5 p. 604 - 610 |
|
~%
Methylprednisol... CAS#:2921-57-5 |
| Literature: Anderson; Taphouse Journal of Pharmaceutical Sciences, 1981 , vol. 70, # 2 p. 181 - 186 |
| HS Code | 2942000000 |
|---|
|
Compatibility of intravenous fosaprepitant with intravenous 5-HT3 antagonists and corticosteroids.
Cancer Chemother. Pharmacol. 72(3) , 509-13, (2013) Fosaprepitant dimeglumine for injection is the water-soluble phosphorylated prodrug of the neurokinin-1 receptor antagonist aprepitant. Both agents are approved (in combination with a 5-HT3 antagonist... |
|
|
A misguided 'pill in the pocket' approach with flecainide leading to cardiac arrest.
BMJ Case Rep. 2012 , doi:10.1136/bcr-2012-006868, (2012)
|
|
|
Shoe contact dermatitis: a case report of an acute severe reaction to potassium dichromate.
Foot (Edinb.) 22(3) , 141-5, (2012) Shoe contact dermatitis is common in both the pediatric and the adult populations. Severity of the reaction can vary greatly by patient.Health Care Professionals of all types should be familiar with s... |
| Urbason-Soluble |
| methylprednisolone 21-hemisuccinate |
| Butanedioic acid, mono[(6α,11β)-11,17-dihydroxy-6-methyl-3,20-dioxopregna-1,4-dien-21-yl] ester |
| MFCD00271782 |
| 4-{[(6α,11β)-11,17-Dihydroxy-6-methyl-3,20-dioxopregna-1,4-dien-21-yl]oxy}-4-oxobutanoic acid |
| Methylprednisolone sodium hemisuccinate |
| 6-methylprednisolone-21-hemisuccinate |
| methylprednisolone hemisuccinate esters |
| Methylprednisolone hydrogen succinate |
| Pregna-1,4-diene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-6-methyl-, (6α,11β)- |
| Solumedrol |
| EINECS 220-863-9 |
| UNII-5GMR90S4KN |
| METHYLPREDNISOLONE SODIUM SUCCINATE |
| 11b,17,21-Trihydroxy-6a-methylpregna-1,4-diene-3,20-dione 21-(Hydrogen Succinate) |
| Methylprednisolone hemisuccinate |
| methylprednisolone succinate |